S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
The 4 highest-shorted large-cap stocks
What’s next for GM stock: Buybacks and a dividend increase
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
US economic growth for last quarter is revised up to a 5.2% annual rate
General Motors, NetApp rise; Petco, Hormel Foods fall, Wednesday, 11/29/2023
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
The 4 highest-shorted large-cap stocks
What’s next for GM stock: Buybacks and a dividend increase
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
US economic growth for last quarter is revised up to a 5.2% annual rate
General Motors, NetApp rise; Petco, Hormel Foods fall, Wednesday, 11/29/2023
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
The 4 highest-shorted large-cap stocks
What’s next for GM stock: Buybacks and a dividend increase
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
US economic growth for last quarter is revised up to a 5.2% annual rate
General Motors, NetApp rise; Petco, Hormel Foods fall, Wednesday, 11/29/2023
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
The 4 highest-shorted large-cap stocks
What’s next for GM stock: Buybacks and a dividend increase
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
US economic growth for last quarter is revised up to a 5.2% annual rate
General Motors, NetApp rise; Petco, Hormel Foods fall, Wednesday, 11/29/2023

Fagron Stock Price, News & Analysis (OTCMKTS:ARSUF)

$17.29
0.00 (0.00%)
(As of 11/29/2023 ET)
Compare
Today's Range
$17.29
$17.29
50-Day Range
$17.29
$17.88
52-Week Range
$16.15
$18.75
Volume
N/A
Average Volume
8,850 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
3.12%
Price Target
N/A

ARSUF stock logo

About Fagron Stock (OTCMKTS:ARSUF)

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

ARSUF Stock Price History

ARSUF Stock News Headlines

Fagron delivers topline growth of 21.5% to €173 million
The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Full year ‘21 results Fagron in line with expectations
See More Headlines
Receive ARSUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fagron and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ARSUF
CIK
N/A
Fax
N/A
Employees
3,035
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Rafael Padilla (Age 45)
    CEO & Executive Director
    Comp: $712.8k
  • Ms. Karin de Jong (Age 44)
    CFO & Executive Director
    Comp: $1.1M
  • Ms. Vera Bakker (Age 51)
    Chief Operating Officer
    Comp: $8.22k
  • Karen Berg
    Global Investor Relations Manager
  • Mr. Johan Verlinden
    Head of Legal, Mergers & Acquisitions














ARSUF Stock Analysis - Frequently Asked Questions

How have ARSUF shares performed in 2023?

Fagron's stock was trading at $13.50 at the beginning of the year. Since then, ARSUF shares have increased by 28.1% and is now trading at $17.2877.
View the best growth stocks for 2023 here
.

Are investors shorting Fagron?

Fagron saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 16,100 shares, an increase of 7.3% from the October 15th total of 15,000 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 161.0 days.
View Fagron's Short Interest
.

Is Fagron a good dividend stock?

Fagron (OTCMKTS:ARSUF) pays an annual dividend of $0.54 per share and currently has a dividend yield of 1.72%.

How do I buy shares of Fagron?

Shares of ARSUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:ARSUF) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -